The Comparative Efficacy and Tolerability of Diclofenac 0.1% and Bromfenac 0.09% Ophthalmic Solutions after Cataract Surgery

Current Eye Research
Giuseppe GiannaccareEmilio C Campos

Abstract

To compare the efficacy and tolerability of diclofenac and bromfenac ophthalmic solutions as adjunctive therapy after cataract surgery. This prospective randomized controlled study included 130 patients who underwent cataract surgery. One hundred patients were randomized to receive postoperatively diclofenac 0.1% (four times daily for 28 days, Group 1) or bromfenac 0.09% (twice daily for 14 days, Group 2) ophthalmic solutions in addition to steroid-antibiotic combination. Thirty patients instilled only steroid-antibiotic combination (Control Group 3). Laser flare-cell photometry and optical coherence tomography scans with central foveal thickness (CFT) measurement were performed before (V0) and 7 (V1), 14 (V2) and 28 days (V3) after surgery. Treatment tolerability was scored using the Ocular Comfort Grading Assessment. Laser flare-cell photometry values were significantly higher at V1, V2 and V3 compared to V0 in all the groups (respectively 13.3 ± 1.0, 12.7 ± 0.9 and 9.6 ± 0.9 vs 8.4 ± 0.6 ph/ms for Group 1; 13.4 ± 1.0, 12.7 ± 0.9 and 12.7 ± 1.0 vs 8.1 ± 0.6 for Group 2; 15.9 ± 0.8, 15.4 ± 0.7 and 14.5 ± 0.7 vs 7.5 ± 0.5 for Group 3) (p < 0.001); flare increase was significantly lower in Group 1 compared to Groups 2 and 3 (p <...Continue Reading

References

Jun 1, 1992·The British Journal of Ophthalmology·O NishiM Imanishi
Jan 1, 1987·Journal of Ocular Pharmacology·L WaterburyR Beuerman
Jul 1, 1999·Current Opinion in Ophthalmology·J Nichols, R W Snyder
Nov 24, 1999·Journal of Cataract and Refractive Surgery·P G UrsellR B Nussenblatt
Feb 24, 2000·The British Journal of Ophthalmology·W R MeacockM R Stanford
Sep 3, 2002·Survey of Ophthalmology·Kensaku Miyake, Nobuhiro Ibaraki
Dec 29, 2004·Survey of Ophthalmology·John G LadasGary N Holland
Oct 3, 2006·Ophthalmology·Sabine KurzH Burkhard Dick
Apr 26, 2008·The AAPS Journal·Munish AhujaDipak K Majumdar
Aug 9, 2008·American Journal of Ophthalmology·John H KempenSivakumar R Rathinam
May 12, 2009·International Ophthalmology·Ilknur Tugal-Tutkun, Carl P Herbort
Feb 18, 2010·Survey of Ophthalmology·Stephen J KimLee M Jampol
Sep 12, 2013·Ophthalmology·Thomas R WaltersUNKNOWN Bromfenac Ophthalmic Solution 0.07% Once Daily Study Group
Aug 26, 2015·Investigative Ophthalmology & Visual Science·Xiang-Jia ZhuPeng Zhou
Dec 30, 2015·Journal of Korean Medical Science·Jong Soo LeeYoung Min Park
Aug 6, 2016·Journal of Cataract and Refractive Surgery·Giuseppe GiannaccarePiera Versura
Jan 21, 2017·American Journal of Ophthalmology·Bobeck S ModjtahediDonald S Fong
Jan 29, 2017·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Ping DuanJiawen Li

❮ Previous
Next ❯

Citations

Jul 11, 2021·Prostaglandins & Other Lipid Mediators·Chen ChenJinling Fu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.